Kamama, Rosda .

HRN: 21-32-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2022
05/14/2022
IVTT
500mg
Q8H
S/p LTCS
Waiting Final Action 
05/07/2022
CEFUROXIME 750MG (VIAL)
05/07/2022
05/08/2022
IV
750mg
Q8
S/P CS
05/08/2022
CEFUROXIME 500MG (TAB)
05/08/2022
05/14/2022
ORAL
500mg/tab
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: